Literature DB >> 8405438

Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle.

D J Wells1.   

Abstract

Gene transfer into skeletal muscle via simple plasmid injection in vivo has many potential uses but these are severely constrained by the low efficiency of this technique. Muscle regeneration, induced by the myotoxic local anaesthetic bupivacaine, significantly increased gene expression following plasmid injection 3-7 days after bupivacaine treatment. Much of this effect can be attributed to uptake and expression of the plasmid by a greater number of muscle fibres, up to 9% of the mouse tibialis anterior muscle. A similar significant increase in expression was observed in the naturally regenerating muscle of the dystrophic mdx mouse when compared to the control C57Bl/10 strain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405438     DOI: 10.1016/0014-5793(93)80508-r

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Molecular cloning of up-regulated cytoskeletal genes from regenerating skeletal muscle: potential role of myocyte enhancer factor 2 proteins in the activation of muscle-regeneration-associated genes.

Authors:  W M Akkila; R L Chambers; O I Ornatsky; J C McDermott
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 2.  Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy.

Authors:  Dominic J Wells
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

3.  Accessibility of T-tubule vacuoles to extracellular dextran and DNA: mechanism and potential application of vacuolation.

Authors:  S A Krolenko; W B Amos; S C Brown; M V Tarunina; J A Lucy
Journal:  J Muscle Res Cell Motil       Date:  1998-08       Impact factor: 2.698

Review 4.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 5.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

6.  Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene.

Authors:  S W Lee; J H Cho; Y C Sung
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector.

Authors:  M J Hariharan; D A Driver; K Townsend; D Brumm; J M Polo; B A Belli; D J Catton; D Hsu; D Mittelstaedt; J E McCormack; L Karavodin; T W Dubensky; S M Chang; T A Banks
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.

Authors:  S Sasaki; T Tsuji; K Hamajima; J Fukushima; N Ishii; T Kaneko; K Q Xin; H Mohri; I Aoki; T Okubo; K Nishioka; K Okuda
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

9.  Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery.

Authors:  T M Pertmer; T R Roberts; J R Haynes
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

10.  Potentiation of antigen-specific, Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-gamma hybrid construct.

Authors:  Y S Lim; B Y Kang; E J Kim; S H Kim; S Y Hwang; T S Kim
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.